fingerlakes17h
FDA approves first new non-opioid painkiller in 20 years
The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
Hosted on MSN21h
Newly FDA-approved non-opioid painkiller is first of its kind in over 20 years
For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
BioSpace1d
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
South Boston Online1d
Important New VERTEX Painkiller Is Approved
By Rick Winterson  Vertex Pharmaceuticals is a worldwide biotechnology corporation. It was founded 35 years ago in Cambridge.  It has now established its global headquarters on Fan Pier in South ...
The Chemical Engineer1d
FDA approves ‘first’ of new class of non-addictive drugs for severe pain
The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...
News on 61d
New non-opioid drug offers hope for pain management
Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...
Psychology Today1d
"Medical" Marijuana and Chronic Pain
Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...
CenExel Celebrates FDA Approval of JOURNAVX(TM), a Groundbreaking Non-Opioid Pain Treatment
SALT LAKE CITY, UTAH / ACCESS Newswire / February 6, 2025 /CenExel, a leading network of clinical research sites, proudly ...
ScienceAlert2d
New Non-Opioid Painkiller First in Decades to Win FDA Approval
A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first ...
Yale Daily News2d
First FDA-approved non-addictive painkiller has Yale roots
Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
Oncology Nurse Advisor2d
Journavx, a Nonopioid Oral Pain Medication, Gets FDA Approval
The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
TheHealthSite3d
US FDA Approves First Ever Non-Opioid Painkiller, Experts Call It A Game Changer
US FDA has approved its first ever non-opioid painkiller called suzetrigine. Experts believe it will prevent addiction problems unlike existing opioids.